apocalyps
avian
influenza
virus
ebola
viru
consid
high
mortal
humantohuman
transmiss
capac
scarc
therapeut
measur
avail
viru
might
finish
case
becom
pandem
phenomena
signific
part
global
popul
persist
current
epidem
believ
due
exist
continu
anim
human
transmiss
least
one
type
anim
reservoir
frequent
contact
peopl
epidem
geograph
area
epidem
spread
sporad
nonmaintain
humantohuman
transmiss
occur
outbreak
associ
health
caregiv
hospit
intrafamili
contact
human
infect
link
direct
contact
camel
dromedari
primari
infect
patient
previous
infect
merscov
secondari
infect
howev
still
larg
group
patient
relationship
two
sourc
infect
proven
date
case
neonat
vertic
transmiss
report
confirm
initi
case
merscov
observ
infect
occur
men
male
femal
ratio
rang
averag
age
year
rang
year
case
report
children
age
averag
incub
period
infect
estim
day
rang
day
patient
report
clinic
symptom
day
seri
interv
repres
time
onset
symptom
case
onset
symptom
contact
estim
day
rang
day
day
case
primari
transmiss
rate
set
hospit
outbreak
secondari
case
intrafamili
contact
transmiss
estim
averag
time
onset
symptom
death
day
rang
epidem
appear
certain
season
distribut
predomin
month
april
may
spring
might
associ
time
birth
rear
new
camel
first
case
report
sever
pneumonia
respiratori
difficulti
extrapulmonari
manifest
initi
symptom
nonspecif
includ
fever
chill
sore
throat
nonproduct
cough
dyspnea
case
poor
prognosi
patient
signific
respiratori
impair
day
radiograph
imag
usual
show
local
system
pneumonia
similar
acut
respiratori
distress
syndrom
one
main
elsevi
slu
right
reserv
extrapulmonari
manifest
acut
renal
failur
occur
patient
infect
merscov
appear
within
day
onset
process
involv
need
kidney
transplant
case
sever
renal
impair
uniqu
specif
clinic
featur
merscov
infect
sinc
sar
epidem
patient
develop
renal
failur
requir
kidney
transplant
presenc
viru
urin
might
impli
direct
particip
renal
condit
although
postul
system
hypoxia
main
caus
patient
merscov
intestin
symptom
seriou
case
suffer
diarrhea
nausea
vomit
possibl
detect
viru
fece
conclus
data
avail
mean
possibl
rout
dissemin
seriou
case
requir
hospit
mainli
primari
case
elderli
patient
comorbid
main
identifi
comorbid
diabet
chronic
renal
diseas
hypertens
chronic
heart
diseas
chronic
lung
diseas
smoke
obes
report
case
respect
although
averag
fatal
rate
highest
level
report
men
age
multipl
comorbid
epidemiolog
studi
environ
famili
hospit
outbreak
shown
exist
complet
asymptomat
case
littl
obviou
symptomatolog
would
report
case
outbreak
asymptomat
case
youngster
children
healthi
women
health
caregiv
therefor
seem
clear
case
report
far
includ
sever
complic
case
requir
hospit
like
number
peopl
infect
merscov
much
higher
accord
seropreval
data
asymptomat
infect
healthi
popul
epidem
much
widespread
initi
expect
endem
epidemiolog
point
view
postul
merscov
infect
similar
observ
sarscov
preval
diseas
among
gener
popul
mani
asymptomat
mild
case
seriou
case
elderli
immunosuppress
patient
retrospect
serolog
studi
shown
merscov
circul
year
first
clinic
case
seroposit
case
detect
peopl
work
direct
contact
anim
slaughterhous
due
sudden
emerg
merscov
without
definit
evid
past
exposur
gener
popul
emerg
new
episod
interspeci
transmiss
new
viru
anim
origin
zoonot
event
postul
accord
studi
genet
concord
conduct
bat
merscov
might
present
anim
reservoir
year
contact
transmiss
bat
human
rare
think
intermedi
host
amplifi
infect
process
vitro
studi
cell
line
shown
merscov
abl
replic
effici
cell
mani
anim
speci
includ
camel
goat
pig
rabbit
hors
civet
viru
abil
infect
cell
speci
tropism
depend
express
dipeptidyl
receptor
these
cell
well
preserv
present
mani
cell
mammal
glycoprotein
merscov
glycoprotein
specif
bind
receptor
locat
surfac
epitheli
endotheli
cell
human
be
includ
lung
kidney
intestin
liver
well
lymphocyt
lung
receptor
locat
pneumocyt
type
alveolar
macrophag
locat
deepest
part
lung
parenchyma
determin
difficulti
respiratori
failur
alveolar
cell
destruct
due
rapid
viral
replic
immun
respons
induc
cytokin
cascad
determin
deterior
respiratori
function
system
manifest
first
evid
support
presenc
intermedi
anim
host
merscov
emerg
presenc
specif
neutral
antibodi
verifi
group
nativ
camel
subsequ
studi
confirm
find
wide
areal
distribut
infect
camel
arabian
peninsula
also
african
countri
therefor
camel
regard
potenti
asymptomat
carrier
reservoir
new
viru
retrospect
serolog
analysi
report
alreadi
seroposit
camel
area
africa
viru
might
arriv
later
current
area
import
seem
confirm
merscov
origin
came
african
bat
cross
first
interspeci
barrier
infect
camel
horn
africa
afterward
viru
arriv
countri
arabian
peninsula
host
eventu
cross
second
interspeci
barrier
infect
human
screen
analysi
merscov
genom
differ
sampl
seroposit
camel
show
nonconst
presenc
nasal
secret
fece
thu
thought
airborn
transmiss
might
droplet
infect
camel
human
direct
contact
confirm
camel
human
transmiss
could
demonstr
definit
genet
analysi
merscov
strain
patient
sever
pneumonia
nasal
aspir
camel
rhinorrhea
own
patient
thu
establish
viru
could
persist
air
around
infect
camel
even
human
respiratori
symptom
least
h
howev
sinc
cultur
possibl
actual
infect
unknown
evid
airborn
transmiss
presuppos
seroposit
camel
would
show
intermitt
sporad
episod
replic
activ
would
associ
respiratori
excret
time
would
remain
activ
nonexcreta
presenc
antibodi
anim
transmiss
newborn
would
definit
protect
effect
viru
prevent
reactiv
process
potenti
reinfect
remain
unclear
whether
camel
simpli
intermedi
amplifi
host
actual
natur
reservoir
merscov
seem
clear
actual
natur
reservoir
bat
primari
reservoir
howev
detect
antibodi
african
camel
year
ago
high
genet
stabil
viru
camel
popul
low
genet
diverg
suspici
adapt
host
high
genet
ident
human
camel
strain
evid
merscov
perfectli
adapt
spread
freeli
among
camel
long
time
therefor
may
becom
natur
secondari
reservoir
rule
exist
anoth
viral
sourc
sinc
confirm
case
lack
contact
anim
human
potenti
infect
rout
camel
also
reevalu
respiratori
rout
appear
like
due
presenc
viru
nasal
conjunctiv
secret
direct
contact
fluid
might
epidemiolog
role
thu
suggest
intak
raw
camel
milk
might
hidden
sourc
infect
viru
abl
surviv
least
h
c
despit
time
elaps
sinc
diagnosi
first
case
merscov
infect
specif
antivir
treatment
avail
proven
signific
clinic
efficaci
larg
number
clinic
trial
conduct
differ
drug
avail
data
provid
definit
conclus
result
yet
thu
vitro
studi
shown
merscov
appear
much
sensit
pegyl
interferon
compar
sarscov
howev
clinic
data
avail
human
effect
nevertheless
combin
interferon
ribavirin
provid
futur
therapeut
hope
perspect
possibl
treatment
patient
life
support
measur
prevent
complic
similarli
specif
vaccin
avail
yet
human
anim
intermedi
camel
appli
prevent
measur
happen
sarscov
appear
use
surfac
glycoprotein
molecul
candid
vaccin
howev
soon
obtain
depend
evolutionari
futur
current
epidem
costbenefit
analysi
prevent
vaccin
target
import
monitor
evolut
spread
current
merscov
epidem
well
genet
variat
new
cov
know
understand
adapt
human
popul
particularli
transmiss
capac
among
individu
epidem
lethal
probabl
decreas
specif
diagnos
support
treatment
initi
earli
therefor
fourth
horseman
apocalyps
becom
local
endem
zoonosi
